---
layout: default
title: Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble
---

# Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble

**arXiv**: [2512.14648v1](https://arxiv.org/abs/2512.14648) | [PDF](https://arxiv.org/pdf/2512.14648.pdf)

**ä½œè€…**: Daniel CapellÃ¡n-MartÃ­n, Abhijeet Parida, Zhifan Jiang, Nishad Kulkarni, Krithika Iyer, Austin Tapp, Syed Muhammad Anwar, MarÃ­a J. Ledesma-Carbayo, Marius George Linguraru

**åˆ†ç±»**: cs.CV, eess.IV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

**å¤‡æ³¨**: 12 pages, 5 figures, 3 tables. Algorithm presented at MICCAI BraTS 2025

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºä¸€ç§åŸºäºŽæ”¾å°„ç»„å­¦å¼•å¯¼å’Œç—…ç¶çº§æ¨¡åž‹é›†æˆçš„è„‘è‚¿ç˜¤è‡ªé€‚åº”åˆ†å‰²æµç¨‹**

ðŸŽ¯ **åŒ¹é…é¢†åŸŸ**: **ç‰©ç†åŠ¨ç”» (Physics-based Animation)**

**å…³é”®è¯**: `è„‘è‚¿ç˜¤åˆ†å‰²` `æ”¾å°„ç»„å­¦` `æ¨¡åž‹é›†æˆ` `è‡ªé€‚åº”åˆ†å‰²` `æ·±åº¦å­¦ä¹ `

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. è„‘è‚¿ç˜¤ç±»åž‹å¤šæ ·ï¼Œå¤šå‚æ•°MRIå›¾åƒåˆ†å‰²é¢ä¸´é²æ£’æ€§å’Œæ³›åŒ–æ€§æŒ‘æˆ˜ã€‚
2. åˆ©ç”¨æ”¾å°„ç»„å­¦ç‰¹å¾æŒ‡å¯¼è‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼Œå®žçŽ°æ›´å¹³è¡¡çš„è®­ç»ƒï¼Œå¹¶ç»“åˆç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡ä¼˜åŒ–æ¨¡åž‹é›†æˆã€‚
3. åœ¨BraTSæŒ‘æˆ˜èµ›æ•°æ®é›†ä¸Šï¼Œè¯¥æµç¨‹å–å¾—äº†ä¸Žé¡¶å°–ç®—æ³•ç›¸å½“çš„æ€§èƒ½ï¼ŒéªŒè¯äº†å…¶æœ‰æ•ˆæ€§ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨å¤šå‚æ•°ç£å…±æŒ¯æˆåƒï¼ˆMRIï¼‰ä¸Šå¯¹è„‘è‚¿ç˜¤è¿›è¡Œé²æ£’ä¸”æ³›åŒ–çš„åˆ†å‰²ä»ç„¶å¾ˆå›°éš¾ï¼Œå› ä¸ºè‚¿ç˜¤ç±»åž‹å·®å¼‚å¾ˆå¤§ã€‚BraTS 2025 Lighthouse Challenge åœ¨æˆäººå’Œå„¿ç«¥è‚¿ç˜¤çš„å¤šæ ·åŒ–é«˜è´¨é‡æ•°æ®é›†ä¸Šå¯¹åˆ†å‰²æ–¹æ³•è¿›è¡ŒåŸºå‡†æµ‹è¯•ï¼ŒåŒ…æ‹¬ï¼šå¤šè”ç›Ÿå›½é™…å„¿ç§‘è„‘è‚¿ç˜¤åˆ†å‰²ï¼ˆPEDï¼‰ã€æœ¯å‰è„‘è†œç˜¤è‚¿ç˜¤åˆ†å‰²ï¼ˆMENï¼‰ã€è„‘è†œç˜¤æ”¾å°„æ²»ç–—åˆ†å‰²ï¼ˆMEN-RTï¼‰ä»¥åŠæ²»ç–—å‰å’Œæ²»ç–—åŽè„‘è½¬ç§»ç˜¤åˆ†å‰²ï¼ˆMETï¼‰ã€‚æˆ‘ä»¬æå‡ºäº†ä¸€ç§çµæ´»ã€æ¨¡å—åŒ–å’Œè‡ªé€‚åº”çš„æµç¨‹ï¼Œé€šè¿‡é€‰æ‹©å’Œç»„åˆæœ€å…ˆè¿›çš„æ¨¡åž‹ï¼Œå¹¶åœ¨è®­ç»ƒå‰åŽåº”ç”¨è‚¿ç˜¤å’Œç—…ç¶ç‰¹å®šçš„å¤„ç†æ¥æé«˜åˆ†å‰²æ€§èƒ½ã€‚ä»Ž MRI ä¸­æå–çš„æ”¾å°„ç»„å­¦ç‰¹å¾æœ‰åŠ©äºŽæ£€æµ‹è‚¿ç˜¤äºšåž‹ï¼Œç¡®ä¿æ›´å¹³è¡¡çš„è®­ç»ƒã€‚è‡ªå®šä¹‰ç—…ç¶çº§åˆ«æ€§èƒ½æŒ‡æ ‡ç¡®å®šæ¯ä¸ªæ¨¡åž‹åœ¨é›†æˆä¸­çš„å½±å“ï¼Œå¹¶ä¼˜åŒ–è¿›ä¸€æ­¥ç»†åŒ–é¢„æµ‹çš„åŽå¤„ç†ï¼Œä½¿å·¥ä½œæµç¨‹èƒ½å¤Ÿé’ˆå¯¹æ¯ä¸ªç—…ä¾‹å®šåˆ¶æ¯ä¸ªæ­¥éª¤ã€‚åœ¨ BraTS æµ‹è¯•é›†ä¸Šï¼Œæˆ‘ä»¬çš„æµç¨‹å®žçŽ°äº†ä¸Žå¤šä¸ªæŒ‘æˆ˜ä¸­æŽ’åé å‰çš„ç®—æ³•ç›¸å½“çš„æ€§èƒ½ã€‚è¿™äº›å‘çŽ°è¯å®žï¼Œè‡ªå®šä¹‰ç—…ç¶æ„ŸçŸ¥å¤„ç†å’Œæ¨¡åž‹é€‰æ‹©å¯ä»¥äº§ç”Ÿé²æ£’çš„åˆ†å‰²ï¼Œè€Œæ— éœ€å°†æ–¹æ³•é”å®šåˆ°ç‰¹å®šçš„ç½‘ç»œæž¶æž„ã€‚æˆ‘ä»¬çš„æ–¹æ³•å…·æœ‰åœ¨ä¸´åºŠå®žè·µä¸­è¿›è¡Œå®šé‡è‚¿ç˜¤æµ‹é‡çš„æ½œåŠ›ï¼Œæ”¯æŒè¯Šæ–­å’Œé¢„åŽã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³å¤šå‚æ•°MRIå›¾åƒä¸­ä¸åŒç±»åž‹è„‘è‚¿ç˜¤çš„ç²¾ç¡®åˆ†å‰²é—®é¢˜ã€‚çŽ°æœ‰æ–¹æ³•éš¾ä»¥åœ¨ä¸åŒè‚¿ç˜¤ç±»åž‹å’Œæ•°æ®é›†ä¸Šä¿æŒé²æ£’æ€§å’Œæ³›åŒ–æ€§ï¼Œéœ€è¦é’ˆå¯¹ç‰¹å®šè‚¿ç˜¤ç±»åž‹è¿›è¡Œè°ƒæ•´ï¼Œç¼ºä¹é€šç”¨æ€§ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯æž„å»ºä¸€ä¸ªçµæ´»ã€æ¨¡å—åŒ–å’Œè‡ªé€‚åº”çš„åˆ†å‰²æµç¨‹ï¼Œè¯¥æµç¨‹èƒ½å¤Ÿæ ¹æ®è‚¿ç˜¤ç±»åž‹å’Œç—…ç¶ç‰¹å¾ï¼Œè‡ªåŠ¨é€‰æ‹©å’Œç»„åˆåˆé€‚çš„åˆ†å‰²æ¨¡åž‹ï¼Œå¹¶è¿›è¡Œé’ˆå¯¹æ€§çš„é¢„å¤„ç†å’ŒåŽå¤„ç†ã€‚é€šè¿‡æ”¾å°„ç»„å­¦ç‰¹å¾æŒ‡å¯¼è‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼Œå®žçŽ°æ›´å¹³è¡¡çš„è®­ç»ƒï¼Œå¹¶åˆ©ç”¨ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡ä¼˜åŒ–æ¨¡åž‹é›†æˆã€‚

**æŠ€æœ¯æ¡†æž¶**ï¼šè¯¥æµç¨‹åŒ…å«ä»¥ä¸‹ä¸»è¦æ¨¡å—ï¼š1) æ•°æ®é¢„å¤„ç†ï¼šåŒ…æ‹¬å›¾åƒé…å‡†ã€æ ‡å‡†åŒ–ç­‰æ“ä½œï¼›2) æ”¾å°„ç»„å­¦ç‰¹å¾æå–ï¼šä»ŽMRIå›¾åƒä¸­æå–æ”¾å°„ç»„å­¦ç‰¹å¾ï¼Œç”¨äºŽè‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼›3) è‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼šåˆ©ç”¨æ”¾å°„ç»„å­¦ç‰¹å¾å¯¹è‚¿ç˜¤è¿›è¡Œäºšåž‹åˆ†ç±»ï¼›4) æ¨¡åž‹é€‰æ‹©ä¸Žé›†æˆï¼šæ ¹æ®è‚¿ç˜¤äºšåž‹é€‰æ‹©åˆé€‚çš„åˆ†å‰²æ¨¡åž‹ï¼Œå¹¶è¿›è¡Œé›†æˆï¼›5) ç—…ç¶çº§åŽå¤„ç†ï¼šæ ¹æ®ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡ï¼Œå¯¹åˆ†å‰²ç»“æžœè¿›è¡Œä¼˜åŒ–ã€‚

**å…³é”®åˆ›æ–°**ï¼šè¯¥æ–¹æ³•æœ€é‡è¦çš„åˆ›æ–°ç‚¹åœ¨äºŽå…¶è‡ªé€‚åº”æ€§ï¼Œèƒ½å¤Ÿæ ¹æ®è‚¿ç˜¤ç±»åž‹å’Œç—…ç¶ç‰¹å¾ï¼Œè‡ªåŠ¨è°ƒæ•´åˆ†å‰²æµç¨‹çš„å„ä¸ªçŽ¯èŠ‚ï¼Œä»Žè€Œæé«˜åˆ†å‰²çš„é²æ£’æ€§å’Œæ³›åŒ–æ€§ã€‚æ­¤å¤–ï¼Œåˆ©ç”¨æ”¾å°„ç»„å­¦ç‰¹å¾æŒ‡å¯¼è‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼Œå¹¶åˆ©ç”¨ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡ä¼˜åŒ–æ¨¡åž‹é›†æˆï¼Œä¹Ÿæ˜¯è¯¥æ–¹æ³•çš„å…³é”®åˆ›æ–°ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡ä¸­ï¼Œæ”¾å°„ç»„å­¦ç‰¹å¾çš„é€‰æ‹©å’Œæå–æ–¹æ³•ã€è‚¿ç˜¤äºšåž‹åˆ†ç±»å™¨çš„è®¾è®¡ã€æ¨¡åž‹é›†æˆçš„ç­–ç•¥ã€ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡çš„å®šä¹‰ä»¥åŠåŽå¤„ç†çš„ä¼˜åŒ–æ–¹æ³•ç­‰éƒ½æ˜¯å…³é”®çš„è®¾è®¡ç»†èŠ‚ã€‚å…·ä½“çš„ç½‘ç»œç»“æž„å’ŒæŸå¤±å‡½æ•°é€‰æ‹©å–å†³äºŽæ‰€ä½¿ç”¨çš„åˆ†å‰²æ¨¡åž‹ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

è¯¥æ–¹æ³•åœ¨BraTS 2025 Lighthouse Challengeçš„å¤šä¸ªå­ä»»åŠ¡ä¸­å–å¾—äº†ä¸Žé¡¶å°–ç®—æ³•ç›¸å½“çš„æ€§èƒ½ï¼Œè¯æ˜Žäº†å…¶åœ¨ä¸åŒç±»åž‹è„‘è‚¿ç˜¤åˆ†å‰²ä»»åŠ¡ä¸­çš„æœ‰æ•ˆæ€§å’Œæ³›åŒ–èƒ½åŠ›ã€‚è¯¥æ–¹æ³•æ— éœ€é”å®šç‰¹å®šç½‘ç»œæž¶æž„ï¼Œå…·æœ‰å¾ˆå¼ºçš„çµæ´»æ€§å’Œå¯æ‰©å±•æ€§ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæžœå¯åº”ç”¨äºŽä¸´åºŠè„‘è‚¿ç˜¤è¯Šæ–­å’Œæ²»ç–—è®¡åˆ’åˆ¶å®šã€‚ç²¾ç¡®çš„è‚¿ç˜¤åˆ†å‰²èƒ½å¤Ÿå¸®åŠ©åŒ»ç”Ÿæ›´å‡†ç¡®åœ°è¯„ä¼°è‚¿ç˜¤çš„å¤§å°ã€ä½ç½®å’Œå½¢æ€ï¼Œä»Žè€Œåˆ¶å®šæ›´æœ‰æ•ˆçš„æ²»ç–—æ–¹æ¡ˆï¼Œå¹¶å¯¹æ²»ç–—æ•ˆæžœè¿›è¡Œè¯„ä¼°ã€‚è¯¥æ–¹æ³•è¿˜å¯ç”¨äºŽè¯ç‰©ç ”å‘ï¼Œè¾…åŠ©è¯„ä¼°è¯ç‰©å¯¹è‚¿ç˜¤çš„ç–—æ•ˆã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Robust and generalizable segmentation of brain tumors on multi-parametric magnetic resonance imaging (MRI) remains difficult because tumor types differ widely. The BraTS 2025 Lighthouse Challenge benchmarks segmentation methods on diverse high-quality datasets of adult and pediatric tumors: multi-consortium international pediatric brain tumor segmentation (PED), preoperative meningioma tumor segmentation (MEN), meningioma radiotherapy segmentation (MEN-RT), and segmentation of pre- and post-treatment brain metastases (MET). We present a flexible, modular, and adaptable pipeline that improves segmentation performance by selecting and combining state-of-the-art models and applying tumor- and lesion-specific processing before and after training. Radiomic features extracted from MRI help detect tumor subtype, ensuring a more balanced training. Custom lesion-level performance metrics determine the influence of each model in the ensemble and optimize post-processing that further refines the predictions, enabling the workflow to tailor every step to each case. On the BraTS testing sets, our pipeline achieved performance comparable to top-ranked algorithms across multiple challenges. These findings confirm that custom lesion-aware processing and model selection yield robust segmentations yet without locking the method to a specific network architecture. Our method has the potential for quantitative tumor measurement in clinical practice, supporting diagnosis and prognosis.

